FORUS Therapeutics is delighted to introduce Deirdre Hay as the Senior Medical Science Liaison for Western Canada. Deirdre has extensive experience in both commercial and medical affairs roles in hematology and oncology, with the last 10 years as a MSL focused on...

We are very pleased to announce that Alison Vanlerberghe has joined the FORUS Therapeutics team as our Market Access Lead. An industry recognized leader in Market Access, Alison brings a wealth of experience and partnership success, having formed multi-stakeholder...

FORUS Therapeutics is pleased to introduce Tom Kowalik as Senior Manager, Commercial Operations and Insights. Tom joins FORUS bringing a wealth of operational and analytical capabilities that will be critical as FORUS establishes the needed knowledge, systems and...

FORUS Therapeutics is pleased to welcome Chris Blowes as Associate Director, Regulatory Affairs. Chris is a highly experienced pharmaceutical industry professional who has supported development and commercial teams throughout numerous product life cycles. Most...

FORUS Therapeutics Inc is excited to announce and welcome Diane Brown who has officially joined the company as Director, Medical and Scientific Affairs. Diane brings over 30 years of Health Care and Industry knowledge with specific leadership experience in building...

FORUS Therapeutics Inc is pleased to welcome Dana Packer as Director, Sales and Marketing. Dana brings deep commercial expertise in oncology and hematology with a proven track record of exceptional results for over 15 years. Prior to joining FORUS Therapeutics Inc,...

(Toronto, Ontario) Le 27 janvier 2021 – Le lancement de FORUS Therapeutics annoncé aujourd’hui, fait entrer une nouvelle société pharmaceutique dans le paysage canadien. Dotée d’une équipe très expérimentée et éprouvée, d’un produit approuvé par la FDA en...